-+ 0.00%
-+ 0.00%
-+ 0.00%

REZOLUTE: PLANS TO CONTINUE EXPANDED ACCESS PROGRAM FOR COMPASSIONATE USE OF ERSODETUG IN TUMOR HI

Reuters·10/14/2026 20:07:49